Innovation
1 patent family (1 granted) — focus: Human necessities; filing pace accelerating. Cited 8 times.
| Year | Filings |
|---|---|
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Social engagement
Social engagement: 4.3K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
5 investors on record; lead investors include CDIB Capital Group.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 80% |
| Private equity | 1 | 20% |
Recent activity
2 Jul 2026
Event
BIOAsia Taiwan 2026
12 Jun 2026
Partnership
EirGenix
27 May 2026
Event
Antibody Therapeutic Conference & 21st Frontiers in Biomedical Sciences Conference